1. Home
  2. CGON vs ENVA Comparison

CGON vs ENVA Comparison

Compare CGON & ENVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CGON
  • ENVA
  • Stock Information
  • Founded
  • CGON 2010
  • ENVA 2011
  • Country
  • CGON United States
  • ENVA United States
  • Employees
  • CGON N/A
  • ENVA N/A
  • Industry
  • CGON
  • ENVA Finance: Consumer Services
  • Sector
  • CGON
  • ENVA Finance
  • Exchange
  • CGON NYSE
  • ENVA Nasdaq
  • Market Cap
  • CGON 2.1B
  • ENVA 2.4B
  • IPO Year
  • CGON 2024
  • ENVA N/A
  • Fundamental
  • Price
  • CGON $26.90
  • ENVA $115.85
  • Analyst Decision
  • CGON Strong Buy
  • ENVA Buy
  • Analyst Count
  • CGON 10
  • ENVA 7
  • Target Price
  • CGON $64.44
  • ENVA $126.33
  • AVG Volume (30 Days)
  • CGON 864.2K
  • ENVA 319.5K
  • Earning Date
  • CGON 08-07-2025
  • ENVA 07-22-2025
  • Dividend Yield
  • CGON N/A
  • ENVA N/A
  • EPS Growth
  • CGON N/A
  • ENVA 52.89
  • EPS
  • CGON N/A
  • ENVA 8.48
  • Revenue
  • CGON $662,000.00
  • ENVA $1,304,376,000.00
  • Revenue This Year
  • CGON N/A
  • ENVA $158.51
  • Revenue Next Year
  • CGON $25,206.93
  • ENVA $12.99
  • P/E Ratio
  • CGON N/A
  • ENVA $13.66
  • Revenue Growth
  • CGON 224.51
  • ENVA 21.58
  • 52 Week Low
  • CGON $14.80
  • ENVA $60.83
  • 52 Week High
  • CGON $40.47
  • ENVA $117.56
  • Technical
  • Relative Strength Index (RSI)
  • CGON 59.29
  • ENVA 82.00
  • Support Level
  • CGON $25.51
  • ENVA $96.57
  • Resistance Level
  • CGON $27.28
  • ENVA $96.95
  • Average True Range (ATR)
  • CGON 1.01
  • ENVA 2.70
  • MACD
  • CGON 0.02
  • ENVA 1.83
  • Stochastic Oscillator
  • CGON 89.23
  • ENVA 95.22

About CGON CG ONCOLOGY INC

CG Oncology Inc is a late-stage clinical biopharmaceutical company focused on developing and commercializing a potential backbone bladder-sparing therapeutic for patients afflicted with bladder cancer. The company's lead candidate, cretostimogene grenadenorepvec, is a targeted oncolytic intravesically delivered immunotherapy agent that is in two phase three trials (one high-risk BCG unresponsive NMIBC trial and one intermediate-risk NMIBC trial) and a phase two clinical study with a checkpoint inhibitor for high-risk BCG unresponsive NMIBC disease.

About ENVA Enova International Inc.

Enova International Inc provides online financial services, including short-term consumer loans, line of credit accounts, and installment loans to customers mainly in the United States and and Brazil. Consumers apply for credit online, the company's technology platforms process the applications, and transactions are completed quickly and efficiently. Its customers are predominantly retail consumers and small businesses. Enova markets its financing products under the names CashNetUSA, NetCredit, OnDeck, Headway Capital, and Simplic. The company also operates a money transfer platform under the name Pangea. Geographically, the company generates a majority of its revenue from its business in the United States and the rest from other international countries.

Share on Social Networks: